ALVO

Alvotech Holdings SA is a pioneering biopharmaceutical company headquartered in Iceland, dedicated to the development and manufacturing of high-quality biosimilars aimed at enhancing patient access to critical biologic therapies. Utilizing advanced technology and a strong emphasis on research and development, Alvotech targets a diverse range of therapeutic areas to meet the increasing global demand for affordable medication alternatives. With its commitment to innovation and quality, the company is strategically positioned to become a leading player in the dynamic biosimilars market.